Mivavotinib
6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one
Molecular Identity
Mivavotinib
6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one
PubChem CID: 53252276
2D Structure
Properties
C17H21FN6O
Molecular Formula
344.40
Molecular Weight
g/mol
344.1761
Exact Mass
Da
0.5
XLogP
Drug-like (Lipinski: < 5)
97.9
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
6
H-Bond Acceptors
508
Complexity
SMILES
Canonical SMILES
SMILES: CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)NC4CCCCC4NIsomeric SMILES
SMILES: CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)N[C@@H]4CCCC[C@@H]4NSynonyms(20)
Mivavotinib1312691-33-0TAK-659 free baseTAK-659F8QR88H79VX6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-oneCB-659TAK6593H-Pyrrolo[3,4-c]pyridin-3-one, 6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-1,2-dihydro-4-(1-methyl-1H-pyrazol-4-yl)-3H-Pyrrolo(3,4-C)pyridin-3-one, 6-(((1R,2S)-2-aminocyclohexyl)amino)-7-fluoro-1,2-dihydro-4-(1-methyl-1H-pyrazol-4-yl)-mivavotinibum6-(((1R,2S)-2-aminocyclohexyl)amino)-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo(3,4-c)pyridin-3-oneTAK659 Free Basesyk Inhibitor TAK659syk-Inhibitor TAK659
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Mivavotinib
Loading drug network...